IPO Databook: Veradermics (MANE US) - Aug 2026

111 Views09 Aug 2026 10:09

SUMMARY

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company developing innovative therapeutics for aesthetic and dermatological conditions, initially focusing on VDPHL01 for pattern hair loss.
Veradermics is developing VDPHL01, an oral, non-hormonal extended-release minoxidil formulation for pattern hair loss affecting 80 million US individuals.
Future sales of registered securities and equity/debt issuances may cause common stock price decline and substantial dilution to existing stockholders.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream